WES Pharma Inc.
FDA inspection history in WESTMINSTER, Maryland, 2023
- 1
- Form 483
Every document, by year
- Form 483
2023: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2023One Form 483, at WESTMINSTER, Maryland.
Cited most
Across all WES Pharma observations on file
- 21 CFR 211.22(d)Responsibilities of quality control unit1
- 21 CFR 211.63Equipment design, size, and location1
The complete WES Pharma file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
WESTMINSTER, Maryland
One Form 483 · 2023 · 2 observations
Latest: Form 483, Nov 21, 2023 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2023-11-21 | 483 Form 483 | WESTMINSTER, Maryland | 2 | $99 |
Investigators on these documents
Johnny D. Nwankwo (1)Olumide A. Akinyemi (1)Pushpa S. Jayasekara (1)Yaharn Su (1)
FEI number 3010062344 · most recent document Nov 21, 2023
About WES Pharma Inc.
How many FDA Form 483s has WES Pharma Inc. received?
FDA Intel has 1 Form 483 on file for WES Pharma Inc.; the most recent is dated Nov 21, 2023.
When was WES Pharma Inc. last inspected by FDA?
The most recent FDA inspection document on file for WES Pharma Inc. is a Form 483 dated Nov 21, 2023, for the site in WESTMINSTER, Maryland.
What did FDA cite at WES Pharma Inc.?
The regulations cited most in the observations on file for WES Pharma Inc. are 21 CFR 211.22(d) (Responsibilities of quality control unit), 1 time; 21 CFR 211.63 (Equipment design, size, and location), 1 time.